Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v5-EN | Version v5-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-03-18 | 2022-03-18 |
| Drug Identification Number | 02240851 | 02240851 |
| Brand name | PROCTODAN-HC SUPPOSITORIES | PROCTODAN-HC SUPPOSITORIES |
| Common or Proper name | Pramoxine HCl, Hydrocortisone Acetate and Zinc Sulfate hemorrhoidal suppositories | Pramoxine HCl, Hydrocortisone Acetate and Zinc Sulfate hemorrhoidal suppositories |
| Company Name | ODAN LABORATORIES LTD | ODAN LABORATORIES LTD |
| Ingredients | ZINC SULFATE HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE | ZINC SULFATE HYDROCORTISONE ACETATE PRAMOXINE HYDROCHLORIDE |
| Strength(s) | 10MG 10MG 20MG | 10MG 10MG 20MG |
| Dosage form(s) | SUPPOSITORY | SUPPOSITORY |
| Route of administration | RECTAL RECTAL | RECTAL RECTAL |
| Packaging size | 12 | 12 |
| ATC code | C05AA | C05AA |
| ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-01-03 | 2022-01-03 |
| Estimated end date | 2022-02-16 | 2022-02-16 |
| Actual end date | 2022-03-17 | 2022-03-17 |
| Shortage status | Resolved | Resolved |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |